CA2144152A1 - Combinaisons d'ibuprofene-cafeine - Google Patents

Combinaisons d'ibuprofene-cafeine

Info

Publication number
CA2144152A1
CA2144152A1 CA002144152A CA2144152A CA2144152A1 CA 2144152 A1 CA2144152 A1 CA 2144152A1 CA 002144152 A CA002144152 A CA 002144152A CA 2144152 A CA2144152 A CA 2144152A CA 2144152 A1 CA2144152 A1 CA 2144152A1
Authority
CA
Canada
Prior art keywords
ibuprofen
lysine
caffeine
salt
enhancement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002144152A
Other languages
English (en)
Inventor
Robert T. Sims
William Slivka
Robert Mcmahon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kenvue Brands LLC
Merck and Co Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2144152A1 publication Critical patent/CA2144152A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002144152A 1992-09-29 1993-09-21 Combinaisons d'ibuprofene-cafeine Abandoned CA2144152A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95342392A 1992-09-29 1992-09-29
US07/953,423 1992-09-29

Publications (1)

Publication Number Publication Date
CA2144152A1 true CA2144152A1 (fr) 1994-04-14

Family

ID=25493974

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002144152A Abandoned CA2144152A1 (fr) 1992-09-29 1993-09-21 Combinaisons d'ibuprofene-cafeine

Country Status (6)

Country Link
EP (1) EP0663819A4 (fr)
JP (1) JPH08501796A (fr)
AU (1) AU5132893A (fr)
CA (1) CA2144152A1 (fr)
MX (1) MX9306005A (fr)
WO (1) WO1994007471A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2150355C (fr) * 1992-12-02 2008-03-11 Robert Hardy Procede d'enrichissenment en un enantiomere donne d'acides phenylpriopioniques au moyen d'alpha-methylbenzylamine
BR9407415A (pt) * 1993-09-07 1996-11-12 Procter & Gamble Composições contendo um sal de aminoácido de agente antiinflamatório não-esteróide de ácido propiônico e caféina
JPH0987174A (ja) * 1995-09-26 1997-03-31 Kobayashi Pharmaceut Co Ltd 鎮痛性および抗炎症性組成物
US6251945B1 (en) * 1999-01-14 2001-06-26 Knoll Aktiengesellschaft Pharmaceutical mixture comprising a combination of a profen and other active compounds
US20090238763A1 (en) * 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
EP3185861A1 (fr) * 2014-08-28 2017-07-05 Sanofi-Aventis Deutschland GmbH Composition pharmaceutique pour le traitement de la douleur aiguë des dents ou des mâchoires

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
WO1992005783A1 (fr) * 1990-09-28 1992-04-16 Merck & Co., Inc. Combinaisons d'ibuprofene-antihistamine

Also Published As

Publication number Publication date
EP0663819A4 (fr) 1998-05-27
MX9306005A (es) 1995-01-31
AU5132893A (en) 1994-04-26
WO1994007471A1 (fr) 1994-04-14
JPH08501796A (ja) 1996-02-27
EP0663819A1 (fr) 1995-07-26

Similar Documents

Publication Publication Date Title
US5164398A (en) Ibuprofen-antitussive combinations
RU2125873C1 (ru) Болеутоляющая композиция и способ достижения болеутоляющего эффекта у человека
US4571400A (en) Dihydrocodeine/ibuprofen pharmaceutical compositions and method
DE69309492T2 (de) Antipyretische und analgetische zusammensetzungen, die optisch reines r-ketorolac enthalten
EP1296671B1 (fr) Analogues de gabapentine pour traiter les troubles du sommeil
WO1994007541A1 (fr) Combinaisons d'ibuprofene-antihistaminique anti-h¿2?
HU225887B1 (en) Process for producing pharmaceutical compositions containing flurbiprofen having painkiller activity
JPH0710749A (ja) Ｓ（＋）−２−（４−イソブチルフェニル）プロピオン酸と塩基性アミノ酸との塩を含有する医薬組成物
US5288507A (en) Ibuprofen antacid combinations
JP2002521329A (ja) フェニルアセチルグルタミン、フェニルアセチルイソグルタミンおよび／または酢酸フェニルの投与のための治療管理
US5260337A (en) Ibuprofen-muscle relaxant combinations
Bagán et al. Clinical comparison of dexketoprofen trometamol and dipyrone in postoperative dental pain
NL8320239A (nl) Verbeterde analgetische en ontstekingsremmende preparaten met daarin ibuprofen, alsmede werkwijze voor het gebruik daarvan.
JP2002520286A (ja) Ｇａｂａ類縁体及びカフェインを含んでなる組成物
NL8320240A (nl) Verbeterde analgetische en antiflogistische, caffeine-bevattende preparaten en werkwijzen voor de toepassing daarvan.
CA2144152A1 (fr) Combinaisons d'ibuprofene-cafeine
WO1994003209A1 (fr) Combinaisons dexibuprofene/antacide/simethicone
US9066950B2 (en) Analgesic compositions
AU672279B2 (en) Compositions containing caffeine and S(+)-ibuprofen or S(+)-flurbiprofen or S(+)-ketoprofen
FR2536996A1 (fr) Association permettant d'ameliorer l'absorption de divers cations par l'organisme
CA1302888C (fr) Agent therapeutique pour le traitement de troubles associes a une ischemie cerebrale
CA2202425A1 (fr) Nouvelle composition anti-spasmodique et anti-inflammatoire et procede de fabrication de cette derniere
Kato et al. Anaphylactic reaction induced by diclofenac
US7074774B2 (en) Use of N-acetyl-D-glucosamine in the manufacture of pharmaceutical useful for treating cardio-cerebrovascular anoxemia
DE3348444C2 (de) Analgetische und antiinflammatorische Mittel

Legal Events

Date Code Title Description
FZDE Dead